We are live on ! Find out more
IMDZ

Immune Design Corp.
IMDZ

Delisted

IMDZ was delisted on the 1st of April, 2019.

71 hedge funds and large institutions have $76.9M invested in Immune Design Corp. in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 22

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

11% less funds holding

Funds holding: 8071 (-9)

29% less capital invested

Capital invested by funds: $108M → $76.9M (-$31.5M)

53% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 17

Holders
71
Holders Change
-9
Holders Change %
-11.25%
% of All Funds
1.62%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
8
Increased
27
Reduced
22
Closed
17
Calls
$327K
Puts
Net Calls
+$327K
Net Calls Change
-$366K

IMDZ Hedge Fund Activity: Q3 2018 in Review

71 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q3 2018, worth a combined $76.9M — down 29% from $108M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of IMDZ and 8 opened new positions — a net loss of 9 holders — while 22 trimmed existing stakes and 27 added.

The largest buyer was BVF Inc, adding an estimated $1.88M. The largest seller was EcoR1 Capital, cutting an estimated $8.24M.

  • 71 institutional investors held Immune Design Corp. (IMDZ) as of Q3 2018, down from 80 in Q2 2018.
  • Funds reported $76.9M of Immune Design Corp. stock for Q3 2018, down 29% quarter-over-quarter.
  • 8 funds opened new Immune Design Corp. positions in Q3 2018 and 17 closed out, a net change of -9 holders.
  • The largest Immune Design Corp. buyer in Q3 2018 was BVF Inc, an estimated $1.88M added.
  • The largest Immune Design Corp. seller in Q3 2018 was EcoR1 Capital, an estimated $8.24M sold.

Based on aggregated 13F filings for Q3 2018.